Earnings FeedTerminal

⌘K

Home/Filings/8-K/0001415889-14-000030

8-K//Current report

ChromaDex Corp. 8-K

Accession 0001415889-14-000030

$NAGECIK 0001386570operating

View on SEC.gov Company Profile

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 4:30 PM ET

Size

129.1 KB

Accession

0001415889-14-000030

Documents

2 files

8-K
cdxc8kdec302013.htmPrimary
EX-10.1
ex10-1.htm
ASSIGNMENT AND ESCROW AGREEMENT BY AND AMONG CHROMADEX CORPORATION, ALPHA CAPITAL ANSTALT, NEUTRISCI INTERNATIONAL INC., BRITLOR HEALTH AND WELLNESS, INC. AND GRUSHKO & MITTMAN, P.C. EFFECTIVE AS OF DECEMBER 27, 2013

Issuer

Niagen Bioscience, Inc.

CIK 0001386570

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001386570

Filing Metadata

Form type: 8-K
Filed: Jan 2, 7:00 PM ET
Accepted: Jan 3, 4:30 PM ET
Size: 129.1 KB

View on SEC.gov